These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 3865481

  • 1. Anabolic steroids and osteoporosis.
    Dequeker J, Geusens P.
    Acta Endocrinol Suppl (Copenh); 1985; 271():45-52. PubMed ID: 3865481
    [No Abstract] [Full Text] [Related]

  • 2. Double-blind placebo-controlled trial of treatment of osteoporosis with the anabolic nandrolone decanoate.
    Need AG, Nordin BE, Chatterton BE.
    Osteoporos Int; 1993; 3 Suppl 1():218-22. PubMed ID: 8461566
    [No Abstract] [Full Text] [Related]

  • 3. [Prophylaxis and treatment of osteoporosis].
    Kopera H.
    Klin Wochenschr; 1989 May 15; 67(10):557-8. PubMed ID: 2739351
    [No Abstract] [Full Text] [Related]

  • 4. Bone mineral content, cortical thickness and fracture rate in osteoporotic women after withdrawal of treatment with nandrolone decanoate, 1-alpha hydroxyvitamin D3, or intermittent calcium infusions.
    Geusens P, Dequeker J, Verstraeten A, Nijs J, Van Holsbeeck M.
    Maturitas; 1986 Dec 15; 8(4):281-9. PubMed ID: 3574141
    [Abstract] [Full Text] [Related]

  • 5. [Effects on the bones of nandrolone decanoate therapy in postmenopausal osteoporosis].
    Gennari C, Agnusdei D, Gonnelli S.
    Minerva Endocrinol; 1989 Dec 15; 14(1):69-74. PubMed ID: 2659955
    [Abstract] [Full Text] [Related]

  • 6. Effects of nandrolone therapy on forearm bone mineral content in osteoporosis.
    Need AG, Horowitz M, Morris HA, Walker CJ, Nordin BE.
    Clin Orthop Relat Res; 1987 Dec 15; (225):273-8. PubMed ID: 3677513
    [Abstract] [Full Text] [Related]

  • 7. Nandrolone decanoate for men with osteoporosis.
    Hamdy RC, Moore SW, Whalen KE, Landy C.
    Am J Ther; 1998 Mar 15; 5(2):89-95. PubMed ID: 10099043
    [Abstract] [Full Text] [Related]

  • 8. Cross-over study of fat-corrected forearm mineral content during nandrolone decanoate therapy for osteoporosis.
    Need AG, Horowitz M, Walker CJ, Chatterton BE, Chapman IC, Nordin BE.
    Bone; 1989 Mar 15; 10(1):3-6. PubMed ID: 2736154
    [Abstract] [Full Text] [Related]

  • 9. Double-blind placebo--controlled trial of nandrolone decanoate in postmenopausal osteoporosis.
    Chhaparwal M, Saraf ML.
    Indian J Med Sci; 1998 Jun 15; 52(6):236-8. PubMed ID: 9849033
    [No Abstract] [Full Text] [Related]

  • 10. Nandrolone decanoate: pharmacological properties and therapeutic use in osteoporosis.
    Geusens P.
    Clin Rheumatol; 1995 Sep 15; 14 Suppl 3():32-9. PubMed ID: 8846659
    [Abstract] [Full Text] [Related]

  • 11. Treatment of postmenopausal osteoporosis: is the anabolic steroid nandrolone decanoate a candidate?
    Johansen JS, Hassager C, Pødenphant J, Riis BJ, Hartwell D, Thomsen K, Christiansen C.
    Bone Miner; 1989 Apr 15; 6(1):77-86. PubMed ID: 2665884
    [Abstract] [Full Text] [Related]

  • 12. Effects of nandrolone decanoate and antiresorptive therapy on vertebral density in osteoporotic postmenopausal women.
    Need AG, Horowitz M, Bridges A, Morris HA, Nordin BE.
    Arch Intern Med; 1989 Jan 15; 149(1):57-60. PubMed ID: 2912415
    [Abstract] [Full Text] [Related]

  • 13. Effects of nandrolone decanoate therapy on bone mass and calcium metabolism in women with established post-menopausal osteoporosis: a double-blind placebo-controlled study.
    Gennari C, AgnusDei D, Gonnelli S, Nardi P.
    Maturitas; 1989 Sep 15; 11(3):187-97. PubMed ID: 2687645
    [Abstract] [Full Text] [Related]

  • 14. A controlled trial of nandrolone decanoate in the treatment of rheumatoid arthritis in postmenopausal women.
    Bird HA, Burkinshaw L, Pearson D, Atkinson PJ, Leatham PA, Hill J, Raven A, Wright V.
    Ann Rheum Dis; 1987 Mar 15; 46(3):237-43. PubMed ID: 3555359
    [Abstract] [Full Text] [Related]

  • 15. Effects of nandrolone decanoate on forearm mineral density and calcium metabolism in osteoporotic postmenopausal women.
    Need AG, Morris HA, Hartley TF, Horowitz M, Nordin BE.
    Calcif Tissue Int; 1987 Jul 15; 41(1):7-10. PubMed ID: 3113703
    [Abstract] [Full Text] [Related]

  • 16. Anabolic steroids in corticosteroid-induced osteoporosis.
    Adami S, Rossini M.
    Wien Med Wochenschr; 1993 Jul 15; 143(14-15):395-7. PubMed ID: 8256456
    [Abstract] [Full Text] [Related]

  • 17. [Osteoporosis in phlebology].
    van der Molen HR, Overvelde S.
    Phlebologie; 1993 Jul 15; 46(2):263-73. PubMed ID: 8362009
    [Abstract] [Full Text] [Related]

  • 18. Effect of nandrolone decanoate on the lipid profile of male peritoneal dialysis patients.
    Mora C, Macía ML, García J, Navarro JF.
    Perit Dial Int; 2001 Jul 15; 21(6):611-4. PubMed ID: 11783772
    [No Abstract] [Full Text] [Related]

  • 19. Long-term effect of nandrolone decanoate, 1 alpha-hydroxyvitamin D3 or intermittent calcium infusion therapy on bone mineral content, bone remodeling and fracture rate in symptomatic osteoporosis: a double-blind controlled study.
    Geusens P, Dequeker J.
    Bone Miner; 1986 Sep 15; 1(4):347-57. PubMed ID: 3333018
    [Abstract] [Full Text] [Related]

  • 20. Androgens, erythropoietin, iron stores, and lipoprotein (a) in hemodialysis patients.
    Fourtounas C, Tzanatos H, Fourtounas C, Kopelias I, Agroyannis B.
    Am J Kidney Dis; 1997 Dec 15; 30(6):935-6. PubMed ID: 9398146
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.